Brian Hubbard brings over 20 years of biopharmaceutical experience. Brian is CEO of Anji Pharmaceuticals and is responsible for its scientific vision and long-term strategy. He has directed R&D efforts at Millennium Pharmaceuticals, Novartis, and Merck in addition to academia. Brian has a proven track record of delivering therapies to the clinic and has founded several biotechnology companies.
Brian received his Ph.D. in Chemistry from the University of Illinois and was a post-doctoral fellow at Harvard Medical School.